These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2250914)

  • 1. Allele loss from chromosome 17 in ovarian cancer.
    Russell SE; Hickey GI; Lowry WS; White P; Atkinson RJ
    Oncogene; 1990 Oct; 5(10):1581-3. PubMed ID: 2250914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
    Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
    Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer.
    Cooke IE; Shelling AN; Le Meuth VG; Charnock ML; Ganesan TS
    Genes Chromosomes Cancer; 1996 Apr; 15(4):223-33. PubMed ID: 8703848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.
    Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PG; Friedlander M; Khoo SK
    Oncogene; 1992 Jun; 7(6):1059-65. PubMed ID: 1594239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele losses on chromosome 17 in human epithelial ovarian carcinoma.
    Eccles DM; Cranston G; Steel CM; Nakamura Y; Leonard RC
    Oncogene; 1990 Oct; 5(10):1599-601. PubMed ID: 2250917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
    Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M
    Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele loss at the c-Ha-ras1 locus in human ovarian cancer.
    Lee JH; Kavanagh JJ; Wharton JT; Wildrick DM; Blick M
    Cancer Res; 1989 Mar; 49(5):1220-2. PubMed ID: 2917352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
    Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
    Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele loss on chromosome 11p is associated with poor survival in ovarian cancer.
    Eccles DM; Gruber L; Stewart M; Steel CM; Leonard RC
    Dis Markers; 1992; 10(2):95-9. PubMed ID: 1360888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
    Eccles DM; Russell SE; Haites NE; Atkinson R; Bell DW; Gruber L; Hickey I; Kelly K; Kitchener H; Leonard R
    Oncogene; 1992 Oct; 7(10):2069-72. PubMed ID: 1408149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allele loss on chromosome 17 in ovarian cystic teratomas.
    Kido M; Ito K; Shibuya M
    Jpn J Clin Oncol; 1994 Aug; 24(4):181-5. PubMed ID: 8072195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic changes associated with ovarian cancer.
    Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
    Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
    Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA
    Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T; Nomura N; Mori H; Wake N
    Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.
    Bova GS; Carter BS; Bussemakers MJ; Emi M; Fujiwara Y; Kyprianou N; Jacobs SC; Robinson JC; Epstein JI; Walsh PC
    Cancer Res; 1993 Sep; 53(17):3869-73. PubMed ID: 7689419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome.
    Smith SA; Easton DF; Evans DG; Ponder BA
    Nat Genet; 1992 Oct; 2(2):128-31. PubMed ID: 1303261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on chromosome 5 in sporadic ovarian carcinoma is a late event and is not associated with mutations in APC at 5q21-22.
    Allan GJ; Cottrell S; Trowsdale J; Foulkes WD
    Hum Mutat; 1994; 3(3):283-91. PubMed ID: 8019564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
    Naylor SL; Johnson BE; Minna JD; Sakaguchi AY
    Nature; 1987 Oct 1-7; 329(6138):451-4. PubMed ID: 2821400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent deletion of chromosome 19 and a rare rearrangement of 19p13.3 involving the insulin receptor gene in human ovarian cancer.
    Amfo K; Neyns B; Teugels E; Lissens W; Bourgain C; De Sutter P; Vandamme B; Vamos E; De Grève J
    Oncogene; 1995 Jul; 11(2):351-8. PubMed ID: 7624149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.